Source: University of Massachusetts Medical School, Worcester
Date: November 17, 2006
Summary:
Two papers published by University of Massachusetts Medical School (UMMS) Department of Cell Biology and Cancer Center investigators report striking changes in control of growth in human embryonic stem cells. The studies were carried out on a National Institutes of Health funded grant using two of the six federal government approved human embryonic stem cell lines.
The implications of this work are significant. There is a pressing need to enhance capabilities for tissue regeneration, particularly for the treatment of age-related skeletal degenerative diseases that include osteoporosis and osteoarthritis, that can be met by stem cells. Utilizing human embryonic stem cells to reverse the catastrophic complications associated with diabetes, renal failure, multiple sclerosis, muscular dystrophy and Alzheimer’s with stem cells is a realistic expectation.
No comments:
Post a Comment